90Y-HPAM4
90Y-HPAM4 Uses, Dosage, Side Effects, Food Interaction and all others data.
90Y-HPAM4 is under investigation in clinical trial NCT00603863 (Safety and Efficacy Study of Different Doses of 90Y-hPAM4 Combined With Gemcitabine in Pancreatic Cancer).
| Trade Name | 90Y-HPAM4 |
| Generic | Yttrium Y-90 clivatuzumab tetraxetan |
| Yttrium Y-90 clivatuzumab tetraxetan Other Names | 90Y-HPAM4 |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here 90Y-HPAM4
